Literature DB >> 11352904

Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.

A Valenzuela-Fernández1, T Palanche, A Amara, A Magerus, R Altmeyer, T Delaunay, J L Virelizier, F Baleux, J L Galzi, F Arenzana-Seisdedos.   

Abstract

The chemokine stromal cell-derived factor 1 (SDF-1) is the natural ligand for CXC chemokine receptor 4 (CXCR4). SDF-1 inhibits infection of CD4+ cells by X4 (CXCR4-dependent) human immunodeficiency virus (HIV) strains. We previously showed that SDF-1 alpha interacts specifically with heparin or heparan sulfates (HSs). Herein, we delimited the boundaries of the HS-binding domain located in the first beta-strand of SDF-1 alpha as the critical residues. We also provide evidence that binding to cell surface heparan sulfate proteoglycans (HSPGs) determines the capacity of SDF-1 alpha to prevent the fusogenic activity of HIV-1 X4 isolates in leukocytes. Indeed, SDF-1 alpha mutants lacking the capacity to interact with HSPGs showed a substantially reduced capacity to prevent cell-to-cell fusion mediated by X4 HIV envelope glycoproteins. Moreover, the enzymatic removal of cell surface HS diminishes the HIV-inhibitory capacity of the chemokine to the levels shown by the HS-binding-disabled mutant counterparts. The mechanisms underlying the optimal HIV-inhibitory activity of SDF-1 alpha when attached to HSPGs were investigated. Combining fluorescence resonance energy transfer and laser confocal microscopy, we demonstrate the concomitant binding of SDF-1 alpha to CXCR4 and HSPGs at the cell membrane. Using FRET between a Texas Red-labeled SDF-1 alpha and an enhanced green fluorescent protein-tagged CXCR4, we show that binding of SDF-1 alpha to cell surface HSPGs modifies neither the kinetics of occupancy nor activation in real time of CXCR4 by the chemokine. Moreover, attachment to HSPGs does not modify the potency of the chemokine to promote internalization of CXCR4. Attachment to cellular HSPGs may co-operate in the optimal anti-HIV activity of SDF-1 alpha by increasing the local concentration of the chemokine in the surrounding environment of CXCR4, thus facilitating sustained occupancy and down-regulation of the HIV coreceptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352904     DOI: 10.1074/jbc.M100411200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

2.  Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection.

Authors:  Agustín Valenzuela-Fernández; Susana Alvarez; Mónica Gordon-Alonso; Marta Barrero; Angeles Ursa; J Román Cabrero; Gerónimo Fernández; Salvador Naranjo-Suárez; Maria Yáñez-Mo; Juan M Serrador; M Angeles Muñoz-Fernández; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2005-09-07       Impact factor: 4.138

3.  Detection of human immunodeficiency virus type 1 Nef and CD4 physical interaction in living human cells by using bioluminescence resonance energy transfer.

Authors:  David Cluet; Christophe Bertsch; Christian Beyer; Liliane Gloeckler; Mathieu Erhardt; Jean-Pierre Gut; Jean-Luc Galzi; Anne-Marie Aubertin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin.

Authors:  Christopher T Veldkamp; Francis C Peterson; Adam J Pelzek; Brian F Volkman
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

5.  Poly (I:C) and LPS induce distinct immune responses by ovarian stromal fibroblasts.

Authors:  Mickey V Patel; Zheng Shen; Charles R Wira
Journal:  J Reprod Immunol       Date:  2018-05-09       Impact factor: 4.054

6.  Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat.

Authors:  Philippe Mavier; Nadine Martin; Dominique Couchie; Anne-Marie Préaux; Yannick Laperche; Elie Serge Zafrani
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  The potent anti-HIV activity of CXCL12gamma correlates with efficient CXCR4 binding and internalization.

Authors:  Jeffrey D Altenburg; Qingwen Jin; Bashar Alkhatib; Ghalib Alkhatib
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions.

Authors:  Mickey V Patel; Mimi Ghosh; John V Fahey; Christina Ochsenbauer; Richard M Rossoll; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

9.  Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.

Authors:  Kazu Okuma; Kevin P Dalton; Linda Buonocore; Elizabeth Ramsburg; John K Rose
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  The lupane-type triterpene 30-oxo-calenduladiol is a CCR5 antagonist with anti-HIV-1 and anti-chemotactic activities.

Authors:  Jonathan Barroso-González; Nabil El Jaber-Vazdekis; Laura García-Expósito; José-David Machado; Rafael Zárate; Angel G Ravelo; Ana Estévez-Braun; Agustín Valenzuela-Fernández
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.